Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M. The definition and classification of cerebral palsy contents foreword historical perspective definition and classification document. Dev Med Child Neurol. 2007;49(109):8–14.
Google Scholar
Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, et al. The updated European consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol. 2010;14(1):45–66.
Article
PubMed
Google Scholar
Register ACP. ACPR Group. Report of the Australian Cerebral Palsy Register, Birth Years 1993–2003. 2009.
Google Scholar
Valentine J, Davidson SA, Bear N, Blair E, Ward R, Thornton A, et al. Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat? Disabil Rehabil. Aug. 2019;15:1–8.
Google Scholar
Vargus-Adams J, Martin LK. Domains of importance for parents, medical professionals and youth with cerebral palsy considering treatment outcomes. Child Care Health Dev. 2011;37:276–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Delgado MR, Hirtz D, Aisen M, Ashwal S, Fehlings DL, McLaughlin J, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;74(4):336–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, et al. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013;55(10):885–910.
Article
PubMed
Google Scholar
Koman L, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum A toxin: preliminary investigation. J Paediatr Orthop. 1993;13(4):489–95.
Article
CAS
Google Scholar
O’flaherty SJ, Janakan V, Morrow AM, Scheinberg AM, Waugh MA. Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy. Dev Med Child Neurol. 2011;53(2):125–30.
Article
PubMed
Google Scholar
Swinney CM, Bau K, Burton KLO, O'Flaherty SJ, Bear NL, Paget SP. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections. Dev Med Child Neurol. 2018;60(5):498–504.
Article
PubMed
Google Scholar
Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, et al. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial. J Pediatr. 2014;165(1):140–6 e4.
Article
CAS
PubMed
Google Scholar
Koman LA, Mooney JF 3rd, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX study group. J Pediatr Orthop. 2000;20(1):108–15.
CAS
PubMed
Google Scholar
Love SC, Valentine JP, Blair EM, Price CJ, Cole JH, Chauvel PJ. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial. Eur J Neurol. 2001;8(Suppl 5):50–8.
Article
PubMed
Google Scholar
Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol. 2000;42(1):32–41.
Article
CAS
PubMed
Google Scholar
Steenbeek D, Meester-Delver A, Becher JG, Lankhorst GJ. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling. Clin Rehabil. 2005;19(3):274–82.
Article
PubMed
Google Scholar
Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, et al. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure. Eur J Neurol. 2001;8:120–6.
Article
PubMed
Google Scholar
Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y. Long-term effects of botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol. 2009;51(2):120–7.
Article
PubMed
Google Scholar
Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst Rev. 2010;20(1):CD003469.
Google Scholar
Lorin K, Forsberg A. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents’ experiences. Child Care Health Dev. 2016;42(4):494–503.
Article
CAS
PubMed
Google Scholar
Delgardo MR, Tilton A, Russman B, Benavides O, Gormley ME, et al. Abobotulinumtoxin A for equinus foot deformity in cerebral palsy: a randomized controlled trial. Pediatrics. 2017;137(2):e20152830.
Article
Google Scholar
Molenaers G, Van Campenhout A, Fagard K, De Cat J, Desloovere K. The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J Child Orthop. 2010;4(3):183–95.
Article
PubMed
PubMed Central
Google Scholar
Kahraman A, Seyhan K, Deger U, Kutluturk S, Mutlu A. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review. Dev Med Child Neurol. 2016;58(8):910–7.
Article
PubMed
Google Scholar
Hastings-Ison T, Blackburn C, Rawicki B, Fahey M, Simpson P, Baker R, et al. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial. Dev Med Child Neurol. 2016;58(7):750–7.
Article
PubMed
Google Scholar
Matthews DJ. Frequency of botulinum toxin injections for spastic equinus: how much is enough? Dev Med Child Neurol. 2016;58(7):657–8.
Article
PubMed
Google Scholar
Gough M. Does botulinum toxin prevent or promote deformity in children with cerebral palsy? Dev Med Child Neurol. 2009;51(2):89–90.
Article
PubMed
Google Scholar
Gough M, Fairhurst C, Shortland AP. Botulinum toxin and cerebral palsy: time for reflection? Dev Med Child Neurol. 2005;47(10):709–12.
Article
CAS
PubMed
Google Scholar
McIntyre S, Novak I, Cusick A. Consensus research priorities for cerebral palsy: a Delphi survey of consumers, researchers, and clinicians. Dev Med Child Neurol. 2010;52(3):270–5.
Article
PubMed
Google Scholar
Gross PH, Bailes AF, Horn SD, Hurvitz EA, Kean J, Shusterman M. Setting a patient-centered research agenda for cerebral palsy: a participatory action research initiative. Dev Med Child Neurol. 2018;60(12):1278–84.
Article
PubMed
Google Scholar
Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214–23.
Article
CAS
PubMed
Google Scholar
Russell DJ, Rosenbaum PL, Avery L, Lane M. Gross motor function measure (GMFM-66 and GMFM-88) user’s manual: clinics in developmental medicine. London: Mac Keith Press; 2002.
Google Scholar
Hanna SE, Bartlett DJ, Rivard LM, Russell DJ. Reference curves for the gross motor function measure: percentiles for clinical description and tracking over time among children with cerebral palsy. Phys Ther. 2008;88(5):596–607.
Article
PubMed
PubMed Central
Google Scholar
Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197–210.
Article
CAS
PubMed
Google Scholar
Coster W, Bedell G, Law M, Khetani MA, Teplicky R, Liljenquist K, et al. Psychometric evaluation of the participation and environment measure for children and youth. Dev Med Child Neurol. 2011;53(11):1030–7.
Article
PubMed
Google Scholar
Palisano RJ, Rosenbaum P, Bartlett D, Livingston MH. Content validity of the expanded and revised gross motor function classification system. Dev Med Child Neurol. 2008;50(10):744–50.
Article
PubMed
Google Scholar
Mitchell LE, Ziviani J, Boyd RN. Characteristics associated with physical activity among independently ambulant children and adolescents with unilateral cerebral palsy. Dev Med Child Neurol. 2015;57(2):167–74.
Article
PubMed
Google Scholar
Russo RN, Miller MD, Haan E, Cameron ID, Crotty M. Pain characteristics and their association with quality of life and self-concept in children with hemiplegic cerebral palsy identified from a population register. Clin J Pain. 2008;24(4):335–42.
Article
PubMed
Google Scholar
Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003;157(12):1219–26.
Article
PubMed
Google Scholar
Berrin SJ, Malcarne VL, Varni JW, Burwinkle TM, Sherman SA, Artavia K, et al. Pain, fatigue, and school functioning in children with cerebral palsy: a path-analytic model. J Pediatr Psychol. 2007;32(3):330–7.
Article
PubMed
Google Scholar
Parkinson KN, Dickinson HO, Arnaud C, Lyons A, Colver A. Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study. Arch Dis Child. 2013;98(6):434.
Article
PubMed
Google Scholar
Alriksson-Schmidt A, Nordmark E, Czuba T, Westbom L. Stability of the gross motor function classification system in children and adolescents with cerebral palsy: a retrospective cohort registry study. Dev Med Child Neurol. 2017;59(6):641–6.
Article
PubMed
Google Scholar
Palisano RJ, Avery L, Gorter JW, Galuppi B, McCoy SW. Stability of the gross motor function classification system, manual ability classification system, and communication function classification system. Dev Med Child Neurol. 2018;60(10):1026–32.
Article
PubMed
Google Scholar
Hanna SERP, et al. Stability and decline in gross motor function among children and youth with cerebral palsy. Dev Med Child Neurol. 2009;51(4):295–302.
Article
PubMed
Google Scholar
Rosenbaum PL, Walter S, Hanna S, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002;288(11):1357–63.
Article
PubMed
Google Scholar
Novak I. Evidence-based diagnosis, health care, and rehabilitation for children with cerebral palsy. J Child Neurol. 2014;29(8):1141–56.
Article
PubMed
Google Scholar
Australian Cerebral Palsy Register G. Report-of-the-Australian-Cerebral-Palsy-Register-Birth-Years-1995-2012. 2018.
Google Scholar
Xu J, Hardy LL, Guo CZ, Garnett SP. The trends and prevalence of obesity and morbid obesity among Australian school-aged children, 1985-2014. J Paediatr Child Health. 2018;54(8):907–12.
Article
PubMed
Google Scholar
Pascoe J, Thomason P, Graham HK, Reddihough D, Sabin MA. Body mass index in ambulatory children with cerebral palsy: a cohort study. J Paediatr Child Health. 2016;52(4):417–21.
Article
PubMed
Google Scholar
Bansal A, Diwan S, Diwan J, Vyas N. Prevalance of obesity in children with cerebral palsy. J Clin Diagn Res. 2014;8(8):BC08–11.
PubMed
PubMed Central
Google Scholar
Ustun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M. The international classification of functioning, disability and health: a new tool for understanding disability and health. Disabil Rehabil. 2003;25(11–12):565–71.
Article
CAS
PubMed
Google Scholar
Bedell GM, Khetani MA, Cousins MA, Coster WJ, Law MC. Parent perspectives to inform development of measures of children's participation and environment. Arch Phys Med Rehabil. 2011;92(5):765–73.
Article
PubMed
Google Scholar
Gisel EG. Stability of three classification systems for cerebral palsy: benefits from multicenter collaboration. Dev Med Child Neurol. 2018;60(10):970–1.
Article
PubMed
Google Scholar
Kolaski K. Botulinum toxin: did the black box warning change how we treat children with cerebral palsy? Dev Med Child Neurol. 2018;60(5):440–1.
Article
PubMed
Google Scholar
Langdon K, Blair E, Davidson SA, Valentine J. Adverse events following botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol. 2010;52(10):972–3 author reply 974.
Article
PubMed
Google Scholar
Williams SA, Reid S, Elliott C, Shipman P, Valentine J. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy. Dev Med Child Neurol. 2013;55(9):813–20.
Article
PubMed
Google Scholar
Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly CJ, et al. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study. Dev Med Child Neurol. 2018;60(11):1165–71.
Article
PubMed
Google Scholar
Valentine J, Stannage K, Fabian V, Ellis K, Reid S, Pitcher C, et al. Muscle histopathology in children with spastic cerebral palsy receiving Botulinum toxin type a. Muscle Nerve. 2016;53:407–14.
Article
CAS
PubMed
Google Scholar
Woolfenden S, Galea C, Smithers-Sheedy H, Blair E, McIntyre S, Reid S, et al. Impact of social disadvantage on cerebral palsy severity. Dev Med Child Neurol. 2019;61(5):586–92.
Article
PubMed
Google Scholar